Evidence map›Paper›PMID 36563015›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2023

Refining the reproducibility of a murine model of stress-induced reversible cardiomyopathy.

Tomohiro Hayashi, Sajal K Tiwary, Kenji Rowel Q Lim, Cibele Rocha-Resende, Attila Kovacs, Carla Weinheimer, Douglas L Mann

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Improving rigor and reproducibility in cardiovascular research.American journal of physiology. Heart and circulatory physiology · 2023
    Article
  9. Article
  10. The Immunology of Takotsubo Syndrome.Frontiers in immunology · 2023
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Tomohiro HayashiCardiovascular Division, Department of Medicine, Center for Cardiovascular Research, Washington University School of Medicine, Saint Louis, Missouri.ORCID 0000-0002-0164-7629
Sajal K TiwaryCardiovascular Division, Department of Medicine, Center for Cardiovascular Research, Washington University School of Medicine, Saint Louis, Missouri.
Kenji Rowel Q LimCardiovascular Division, Department of Medicine, Center for Cardiovascular Research, Washington University School of Medicine, Saint Louis, Missouri.ORCID 0000-0002-5484-4183
Cibele Rocha-ResendeDepartment of Physiology and Biophysics, Federal University of Minas Gerais, Belo Horizonte, Brazil.ORCID 0000-0002-5109-0654
Attila KovacsCardiovascular Division, Department of Medicine, Center for Cardiovascular Research, Washington University School of Medicine, Saint Louis, Missouri.
Carla WeinheimerCardiovascular Division, Department of Medicine, Center for Cardiovascular Research, Washington University School of Medicine, Saint Louis, Missouri.ORCID 0000-0001-7922-7512
Douglas L MannCardiovascular Division, Department of Medicine, Center for Cardiovascular Research, Washington University School of Medicine, Saint Louis, Missouri.ORCID 0000-0002-2516-0145
Washington University in St. Louis · USUniversidade Federal de Minas Gerais · BR

Funding

Treating secondary cardiomyopathies by mimicking the adaptive hepatic glucose fasting responseR01HL147968 · NHLBI · WASHINGTON UNIVERSITY · PI DEBOSCH, BRIAN JESSE · 2020 to 2024
$3.2M
Apolipoprotein M: a novel regulator of myocardial AutophagyR01HL155344 · NHLBI · WASHINGTON UNIVERSITY · PI JAVAHERI, ALI · 2021 to 2025
$3.1M
HIGH-RESOLUTON ULTRASOUND SYSTEM FOR PHENOTYPIC EVALUATION OF THE CARDIOVASCULAR SYSTEM IN MICES10OD028597 · OD · WASHINGTON UNIVERSITY · PI KOVACS, ATTILA · 2020 to 2020
$378k
NHLBI NIH HHS R01 HL147968NHLBI NIH HHS R01 HL155344NIH HHS R01HL147968NIH HHS R01 HL155344NIH HHS S10 OD028597
6 · The paper itself

Abstract

Despite the many advantages of isoproterenol (Iso)-induced models of cardiomyopathy, the extant literature suggests that the reproducibility of the Iso-induced stress cardiomyopathy phenotype varies considerably depending on the dose of Iso used, the mode of administration of Iso (subcutaneous vs. intraperitoneal), and the species of the animal that is being studied. Recently, we have shown that a single injection of Iso into female C57BL/6J mice provokes transient myocardial injury that is characterized by a brisk release of troponin I within 1 h, as well as a self-limited myocardial inflammatory response that is associated with increased myocardial tissue edema, inferoapical regional left ventricular (LV) wall motion abnormalities, and a transient decrease in global LV function, which were completely recovered by

Indexed as

CardiomyopathiesDisease Models, AnimalAnimalsFemaleHumansIsoproterenolMiceMice, Inbred C57BLReproducibility of ResultsTroponin IIsoproterenolTroponin Iinflammationreproducibilitysextissue injury

Identifiers

PMID36563015
PMCPMC9886343
OpenAlexW4312115122

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.